Physician profile
Derek M Voss
NPI 1851824221
$5,303.35
in general payments reported to CMS, 2019-2025
11 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.59 · 2021: $34.15 · 2022: $71.17 · 2023: $2,325 · 2024: $2,686 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,770 · Food and Beverage: $1,393 · Education: $1,000 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,770.48 |
| Food and Beverage | $1,392.97 |
| Education | $1,000.00 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,848.30 | 2023-2024 | Da Vinci Surgical System, Davinci Xi |
| Boston Scientific Corporation | $943.53 | 2024 | Solyx Sis System |
| Hologic Sales and Service, LLC | $124.13 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $115.20 | 2024 | Veozah |
| Myovant Sciences INC. | $71.17 | 2022 | |
| Minerva Surgical, INC | $67.01 | 2023 | |
| Abbvie INC. | $36.71 | 2020-2021 | |
| Axonics, INC. | $36.56 | 2024 | Bulkamid, Axonics |
| Medtronic, INC. | $22.79 | 2025 | Truclear |
| Coopersurgical, INC. | $20.92 | 2025 | Paragard T 380a |
| Ethicon US, LLC | $17.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Voss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.